BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21258152)

  • 1. Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.
    Pietroboni AM; Fumagalli GG; Ghezzi L; Fenoglio C; Cortini F; Serpente M; Cantoni C; Rotondo E; Corti P; Carecchio M; Bassi M; Bresolin N; Galbiati D; Galimberti D; Scarpini E
    J Alzheimers Dis; 2011; 24(2):253-9. PubMed ID: 21258152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene.
    Marcon G; Rossi G; Giaccone G; Giovagnoli AR; Piccoli E; Zanini S; Geatti O; Toso V; Grisoli M; Tagliavini F
    J Alzheimers Dis; 2011; 26(3):583-90. PubMed ID: 21677378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct genetic forms of frontotemporal dementia.
    Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
    Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation.
    Larner AJ
    J Neurol Sci; 2012 May; 316(1-2):189-90. PubMed ID: 22280948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.
    Calvi A; Cioffi SM; Caffarra P; Fenoglio C; Serpente M; Pietroboni AM; Arighi A; Ghezzi L; Gardini S; Scarpini E; Galimberti D
    J Alzheimers Dis; 2015; 44(1):277-82. PubMed ID: 25261445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin.
    Caroppo P; Le Ber I; Camuzat A; Clot F; Naccache L; Lamari F; De Septenville A; Bertrand A; Belliard S; Hannequin D; Colliot O; Brice A
    JAMA Neurol; 2014 Dec; 71(12):1562-6. PubMed ID: 25317628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder.
    Cerami C; Marcone A; Galimberti D; Villa C; Scarpini E; Cappa SF
    J Alzheimers Dis; 2011; 27(4):791-7. PubMed ID: 21891869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
    Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D
    J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation.
    Pires C; Coelho M; Valadas A; Barroso C; Pimentel J; Martins M; Duyckaerts C; de Mendonça A; Verdelho A; Miltenberger-Miltenyi G
    J Alzheimers Dis; 2013; 37(2):335-42. PubMed ID: 23813535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
    Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
    J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype.
    Caso F; Villa C; Fenoglio C; Santangelo R; Agosta F; Coppi E; Falautano M; Comi G; Filippi M; Scarpini E; Magnani G; Galimberti D
    J Alzheimers Dis; 2012; 28(4):759-63. PubMed ID: 22072213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
    Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers.
    Barandiaran M; Estanga A; Moreno F; Indakoetxea B; Alzualde A; Balluerka N; Martí Massó JF; López de Munain A
    J Int Neuropsychol Soc; 2012 Nov; 18(6):1086-90. PubMed ID: 23158232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early neuropsychological characteristics of progranulin mutation carriers.
    Hallam BJ; Jacova C; Hsiung GY; Wittenberg D; Sengdy P; Bouchard-Kerr P; Slack P; Rademakers R; Baker M; Chow TW; Levine B; Feldman HH; Mackenzie IR
    J Int Neuropsychol Soc; 2014 Aug; 20(7):694-703. PubMed ID: 24993774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration.
    Borroni B; Bonvicini C; Galimberti D; Tremolizzo L; Papetti A; Archetti S; Turla M; Alberici A; Agosti C; Premi E; Appollonio I; Rainero I; Ferrarese C; Gennarelli M; Scarpini E; Padovani A
    Neurobiol Aging; 2011 Mar; 32(3):555.e1-8. PubMed ID: 20947212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.